Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

ClinicalTrials.gov ID: NCT06701526

Public ClinicalTrials.gov record NCT06701526. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 1:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Open-label Trial, Investigating the Effectiveness of Eptinezumab in Participants With Migraine and Previous Inadequate Response to CGRP-targeting Therapies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).

Study identification

NCT ID
NCT06701526
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
164 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 2024
Primary completion
Jun 4, 2026
Completion
Jun 4, 2026
Last update posted
May 12, 2026

2024 – 2026

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Neuropain Medical Center Fresno California 93710
Sunwise Clinical Research, LLC. Oakland California 94596
The Neuron Clinic San Marcos California 92069
St. Joseph's Hospital and Medical Center - Barrow Neurological Institute Aurora Colorado 80045
Advanced Neurology of Colorado, LLC Longmont Colorado 80501
Research of the Rockies Parker Colorado 80138
Hasbani & Hasbani MDs New Haven Connecticut 06511
New England Institute for Neurology and Headache Stamford Connecticut 06905
Brainstorm Research Miami Florida 33176
Premiere Research Institute at Palm Beach Neurology West Palm Beach Florida 33407
PANDA Neurology and Atlanta Headache Specialists Atlanta Georgia 30328
St Luke's Meridian Medical Center Meridian Idaho 83642
Chicago Headache Center & Research Institute Chicago Illinois 60657
Crescent City Headache and Neurology New Orleans Louisiana 70115
Neurology Center of New England P.C. Foxborough Massachusetts 02035
MedVadis Research Corporation Waltham Massachusetts 02451
Mass Institute of Clinical Research Westborough Massachusetts 01581
Memorial Healthcare Owosso Michigan 48867
Albany Medical College Albany New York 12230
Dent Neurosciences Research Center, Inc. Amherst New York 14226
North Suffolk Neurology Port Jefferson Station New York 11776
NeuroScience Research Center, LLC. Canton Ohio 44718
C7 Research Cleveland Ohio 44109
Thomas Jefferson University Philadelphia Pennsylvania 19107
Preferred Primary Care Physicians, Inc. Pittsburgh Pennsylvania 15236
KCA Neurology, PLLC Franklin Tennessee 37067
Texas Neurology, PA Dallas Texas 75206-5202
Inova Health Care Services Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06701526, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2026 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06701526 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →